Dr. Thomas (TJ) Pugh is the Director of Radiation Oncology at TUCC and the only radiation oncologist in Colorado whose practice is solely devoted to the treatment of genitourinary cancers. He is board-certified in radiation oncology by the American Board of Radiology. Dr. Pugh joined TUCC in 2020 from the University of Colorado Hospital where he previously worked as an Associate Professor and Vice-Chair for Clinical Affairs.
Dr. Pugh obtained a Bachelor of Arts degree from the University of Kansas; which he attended on a basketball scholarship. He was one of seven athletes nationally to be awarded a post-graduate scholarship by the national collegiate athletic association (NCAA) for academic and athletic achievement. He obtained his medical doctorate from the University of Colorado and spent a year as an internal medicine intern at the University of Colorado Hospital. He completed his residency training in Radiation Oncology at the University of Colorado Hospital, where he also served as Chief Resident. He completed a prostate cancer brachytherapy fellowship at the Seattle Prostate Institute in Seattle, WA sponsored by the American Brachytherapy Society.
He has specialized in genitourinary cancer since 2010, when he started his practice at MD Anderson Cancer Center. During his time in Houston, he rapidly became known as a talented clinician and thought leader in cancer medicine.
Dr. Pugh’s professional interests include advanced technology integration into cancer therapeutics, prostate brachytherapy, proton beam therapy, image-guide radiation therapy (IGRT), stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and integration of medical therapeutics, including chemotherapy and hormone therapy, with radiation therapy.
Dr. Pugh is an internationally recognized expert in Genitourinary Cancers and has served on the National Comprehensive Cancer Network (NCCN) Guideline Panel for Prostate Cancer Treatment. He has published over 100 peer-reviewed articles, abstracts, and book chapters focused on improving the quality of care for men with prostate cancer.